252 related articles for article (PubMed ID: 33206388)
1. Lung cancer screening eligibility and use with low-dose computed tomography: Results from the 2018 Behavioral Risk Factor Surveillance System cross-sectional survey.
Narayan AK; Gupta Y; Little BP; Shepard JO; Flores EJ
Cancer; 2021 Mar; 127(5):748-756. PubMed ID: 33206388
[TBL] [Abstract][Full Text] [Related]
2. Assessing Eligibility for Lung Cancer Screening Among Women Undergoing Screening Mammography: Cross-Sectional Survey Results From the National Health Interview Survey.
López DB; Flores EJ; Miles RC; Wang GX; Glover M; Shepard JO; Lehman CD; Narayan AK
J Am Coll Radiol; 2019 Oct; 16(10):1433-1439. PubMed ID: 31092347
[TBL] [Abstract][Full Text] [Related]
3. Lung Cancer Screening Eligibility and Utilization Among Transgender Patients: An Analysis of the 2017-2018 United States Behavioral Risk Factor Surveillance System Survey.
Stowell JT; Parikh Y; Tilson K; Narayan AK
Nicotine Tob Res; 2020 Dec; 22(12):2164-2169. PubMed ID: 32623455
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with low-dose CT lung cancer screening participation in a high burden state: Results from the 2017-2018 BRFSS.
Sedani AE; Ford LA; James SA; Beebe LA
J Cancer Policy; 2021 Jun; 28():100284. PubMed ID: 35559913
[TBL] [Abstract][Full Text] [Related]
8. Lung Cancer Screening Eligibility and Use: A Population Health Perspective of One Community.
Tailor TD; Farrow NE; Gao J; Choudhury KR; Tong BC
N C Med J; 2021; 82(5):321-326. PubMed ID: 34544766
[No Abstract] [Full Text] [Related]
9. Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers.
Raju S; Khawaja A; Han X; Wang X; Mazzone PJ
Clin Lung Cancer; 2020 Sep; 21(5):e329-e336. PubMed ID: 32371161
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
Advani S; Zhang D; Tammemagi M; Akinyemiju T; Gould MK; Silvestri GA; Braithwaite D
Ann Am Thorac Soc; 2021 Nov; 18(11):1886-1893. PubMed ID: 33939595
[No Abstract] [Full Text] [Related]
11. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
[TBL] [Abstract][Full Text] [Related]
12. Likelihood of Lung Cancer Screening by Poor Health Status and Race and Ethnicity in US Adults, 2017 to 2020.
Rustagi AS; Byers AL; Keyhani S
JAMA Netw Open; 2022 Mar; 5(3):e225318. PubMed ID: 35357450
[TBL] [Abstract][Full Text] [Related]
13. Augmented meaningful use criteria to identify patients eligible for lung cancer screening.
Raz DJ; Dunham R; Tiep B; Sandoval A; Grannis F; Rotter A; Kim JY
Ann Thorac Surg; 2014 Sep; 98(3):996-1002. PubMed ID: 25063304
[TBL] [Abstract][Full Text] [Related]
14. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
[TBL] [Abstract][Full Text] [Related]
15. New recommendation and coverage of low-dose computed tomography for lung cancer screening: uptake has increased but is still low.
Li J; Chung S; Wei EK; Luft HS
BMC Health Serv Res; 2018 Jul; 18(1):525. PubMed ID: 29976189
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
[No Abstract] [Full Text] [Related]
17. Lung Cancer Screening in the US, 2022.
Bandi P; Star J; Ashad-Bishop K; Kratzer T; Smith R; Jemal A
JAMA Intern Med; 2024 Jun; ():. PubMed ID: 38856988
[TBL] [Abstract][Full Text] [Related]
18. State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States.
Fedewa SA; Kazerooni EA; Studts JL; Smith RA; Bandi P; Sauer AG; Cotter M; Sineshaw HM; Jemal A; Silvestri GA
J Natl Cancer Inst; 2021 Aug; 113(8):1044-1052. PubMed ID: 33176362
[TBL] [Abstract][Full Text] [Related]
19. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
20. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
